But with so many new options, including dual and triple agonists, its normal to have questions about how they work and whether theyre right for you
Among all adult patients prescribed a GLP-1 drug, the percentage who had an overweight or obesity diagnosis and no type 2 diabetes diagnosis increased from 3.7 percent in 2019 to 16.5 percent in 2024, a relative increase of 344.4 percent
Weeks 1-4, Weeks 5-8 28 syringes 1 syringe per daily administration
Using expired semaglutide can lead to insufficient blood sugar management or diminished weight-loss advantages, as the treatment may not work as intended
If you do not think you will use your entire vial within that window, discuss smaller-dose vials or adjusted injection schedules with your PlexusDx provider to minimize waste
Benefits of GLP-1 (glucagon-like peptide 1) receptor agonists for stroke reduction in type 2 diabetes: a call to action for neurologists